191 related articles for article (PubMed ID: 34233454)
41. MicroRNA-145 targeted therapy reduces atherosclerosis.
Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta N; Steer BM; Ingram AJ; Gupta M; Al-Omran M; Teoh H; Marsden PA; Verma S
Circulation; 2012 Sep; 126(11 Suppl 1):S81-90. PubMed ID: 22965997
[TBL] [Abstract][Full Text] [Related]
42. Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death.
Seijkens TTP; Poels K; Meiler S; van Tiel CM; Kusters PJH; Reiche M; Atzler D; Winkels H; Tjwa M; Poelman H; Slütter B; Kuiper J; Gijbels M; Kuivenhoven JA; Matic LP; Paulsson-Berne G; Hedin U; Hansson GK; Nicolaes GAF; Daemen MJAP; Weber C; Gerdes N; de Winther MPJ; Lutgens E
Eur Heart J; 2019 Jan; 40(4):372-382. PubMed ID: 30452556
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability.
Wezel A; Welten SM; Razawy W; Lagraauw HM; de Vries MR; Goossens EA; Boonstra MC; Hamming JF; Kandimalla ER; Kuiper J; Quax PH; Nossent AY; Bot I
Ann Surg; 2015 Nov; 262(5):841-7; discussion 847-8. PubMed ID: 26583674
[TBL] [Abstract][Full Text] [Related]
44. Bone marrow-specific knock-in of a non-activatable Ikkα kinase mutant influences haematopoiesis but not atherosclerosis in Apoe-deficient mice.
Tilstam PV; Gijbels MJ; Habbeddine M; Cudejko C; Asare Y; Theelen W; Zhou B; Döring Y; Drechsler M; Pawig L; Simsekyilmaz S; Koenen RR; de Winther MP; Lawrence T; Bernhagen J; Zernecke A; Weber C; Noels H
PLoS One; 2014; 9(2):e87452. PubMed ID: 24498325
[TBL] [Abstract][Full Text] [Related]
45. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
46. SREBF1/MicroRNA-33b Axis Exhibits Potent Effect on Unstable Atherosclerotic Plaque Formation In Vivo.
Nishino T; Horie T; Baba O; Sowa N; Hanada R; Kuwabara Y; Nakao T; Nishiga M; Nishi H; Nakashima Y; Nakazeki F; Ide Y; Koyama S; Kimura M; Nagata M; Yoshida K; Takagi Y; Nakamura T; Hasegawa K; Miyamoto S; Kimura T; Ono K
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2460-2473. PubMed ID: 30354203
[TBL] [Abstract][Full Text] [Related]
47. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
48. Dickkopf-3 Ablation Attenuates the Development of Atherosclerosis in ApoE-Deficient Mice.
Cheng WL; Yang Y; Zhang XJ; Guo J; Gong J; Gong FH; She ZG; Huang Z; Xia H; Li H
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219919
[TBL] [Abstract][Full Text] [Related]
49. Rhythm changes of clock genes, apoptosis-related genes and atherosclerosis-related genes in apolipoprotein E knockout mice.
Xu C; Lu C; Hua L; Jin H; Yin L; Chen S; Qian R
Can J Cardiol; 2009 Aug; 25(8):473-9. PubMed ID: 19668782
[TBL] [Abstract][Full Text] [Related]
50. Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E
Rinne P; Kadiri JJ; Velasco-Delgado M; Nuutinen S; Viitala M; Hollmén M; Rami M; Savontaus E; Steffens S
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):313-323. PubMed ID: 29284608
[TBL] [Abstract][Full Text] [Related]
51. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
52. Chronic over-expression of heat shock protein 27 attenuates atherogenesis and enhances plaque remodeling: a combined histological and mechanical assessment of aortic lesions.
Cuerrier CM; Chen YX; Tremblay D; Rayner K; McNulty M; Zhao X; Kennedy CR; de BelleRoche J; Pelling AE; O'Brien ER
PLoS One; 2013; 8(2):e55867. PubMed ID: 23409070
[TBL] [Abstract][Full Text] [Related]
53. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
[TBL] [Abstract][Full Text] [Related]
54. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.
Yamamoto S; Yancey PG; Zuo Y; Ma LJ; Kaseda R; Fogo AB; Ichikawa I; Linton MF; Fazio S; Kon V
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2856-64. PubMed ID: 21979434
[TBL] [Abstract][Full Text] [Related]
55. Mechanism of efferocytosis in atherosclerosis.
Shu LX; Cao LL; Guo X; Wang ZB; Wang SZ
J Mol Med (Berl); 2024 Jul; 102(7):831-840. PubMed ID: 38727748
[TBL] [Abstract][Full Text] [Related]
56. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
[TBL] [Abstract][Full Text] [Related]
57. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
58. Cathepsin G deficiency decreases complexity of atherosclerotic lesions in apolipoprotein E-deficient mice.
Rafatian N; Karunakaran D; Rayner KJ; Leenen FH; Milne RW; Whitman SC
Am J Physiol Heart Circ Physiol; 2013 Oct; 305(8):H1141-8. PubMed ID: 23934850
[TBL] [Abstract][Full Text] [Related]
59. Effect of hyperlipidemia on the expression of circadian genes in apolipoprotein E knock-out atherosclerotic mice.
Hou L; Lu C; Huang Y; Chen S; Hua L; Qian R
Lipids Health Dis; 2009 Dec; 8():60. PubMed ID: 20040117
[TBL] [Abstract][Full Text] [Related]
60. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
